Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMISULPRIDE vs AMLODIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMISULPRIDE vs AMLODIPINE: Safety Overview

Metric AMISULPRIDE AMLODIPINE
Total FAERS Reports 3,152 64,924
Deaths Reported 324 10,161
Death Rate 10.3% 15.7%
Hospitalizations 1,537 26,787
Average Patient Age 42.7 yrs 62.8 yrs
% Female Patients 41.3% 57.0%
FDA Approval Date Feb 26, 2020 Apr 12, 2011
Manufacturer Acacia Pharma Ltd Teva Pharmaceuticals USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription